Adjunctive Study of AL-37807 Ophthalmic Suspension
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the safety and intraocular pressure-lowering efficacy
of AL-37807 ophthalmic suspension vs. Timolol gel forming solution vs. AL-37807 vehicle, all
dosed concomitantly with Xalatan, in patients with open-angle glaucoma or ocular
hypertension.